Breaking News

Lilly to Invest $2.1B in Indiana Manufacturing Sites

Two new facilities will expand Lilly's manufacturing network for active ingredients and new therapeutic modalities.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Eli Lilly and Company plans to expand its manufacturing footprint in Indiana by investing $2.1 billion in two new manufacturing sites at Indiana’s LEAP Lebanon Innovation and Research District in Boone County. These new facilities will expand Lilly’s manufacturing network for active ingredients and new therapeutic modalities, such as genetic medicines. “More than 146 years after our founding, Lilly remains committed to investing and innovating in Indiana,” said Davi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters